跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Lamictal
Approved
STANDARD
Lamictal
GlaxoSmithKline Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
abf6413e4e203411
Company
GlaxoSmithKline Pharmaceuticals
Type
Standard
Approval Details
Approval Id
abf6413e4e203411
Drug Approval Philippines Name
Lamictal
Product Name
Lamictal
Registration Number
DR-XY17652
Brand Name
Lamictal
Generic Name
Lamotrigine
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
GlaxoSmithKline Pharmaceuticals
Importer
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/glaxosmithkline-pharmaceuticals
Issuance Date
12 September 2022
Expiry Date
24 November 2027
Pharmacologic Category
Anti-epileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
abf6413e4e203411
Type
Standard
Back to Philippines FDA Approvals
Lamictal - Philippines FDA Drug Approval Details